Literature DB >> 6337059

Plasmodium falciparum: assessment of in vitro growth by [3H]hypoxanthine incorporation.

J D Chulay, J D Haynes, C L Diggs.   

Abstract

To evaluate rapidly Plasmodium falciparum growth in Vitro, [3H]hypoxanthine was added to parasite microcultures and radioisotope incorporation was measured. When culture parameters were carefully controlled, [3H]hypoxanthine incorporation was proportional to the number of parasitized erythrocytes present. Factors affecting [3H]hypoxanthine incorporation included initial parasitemia, duration of culture, duration of radioisotope pulse, parasite stage, concentration of uninfected erythrocytes, the use of serum or plasma to supplement growth, and the concentration of a variety of purines in the culture medium. The method described can be used to measure inhibition of P. falciparum growth by immune serum and has previously been used to study antimalarial drug activity in vitro.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337059     DOI: 10.1016/0014-4894(83)90007-3

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  49 in total

1.  Synthesis and evaluation of 4-quinazolinone compounds as potential antimalarial agents.

Authors:  Shuren Zhu; Joe Wang; Gudise Chandrashekar; Erika Smith; Xianjun Liu; Yongshen Zhang
Journal:  Eur J Med Chem       Date:  2010-05-24       Impact factor: 6.514

2.  Efficacy of proton pump inhibitor drugs against Plasmodium falciparum in vitro and their probable pharmacophores.

Authors:  Michael A Riel; Dennis E Kyle; Apurba K Bhattacharjee; Wilbur K Milhous
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

3.  Eosin B as a novel antimalarial agent for drug-resistant Plasmodium falciparum.

Authors:  Kristen M Massimine; Michael T McIntosh; Lanxuan T Doan; Chloé E Atreya; Stephan Gromer; Worachart Sirawaraporn; David A Elliott; Keith A Joiner; R Heiner Schirmer; Karen S Anderson
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.

Authors:  Jacob D Johnson; Richard A Dennull; Lucia Gerena; Miriam Lopez-Sanchez; Norma E Roncal; Norman C Waters
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

5.  MK-4815, a potential new oral agent for treatment of malaria.

Authors:  Mary Ann Powles; John Allocco; Lai Yeung; Bakela Nare; Paul Liberator; Dennis Schmatz
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

6.  Synthesis and evaluation of febrifugine analogues as potential antimalarial agents.

Authors:  Shuren Zhu; Li Meng; Quan Zhang; Lai Wei
Journal:  Bioorg Med Chem Lett       Date:  2006-01-24       Impact factor: 2.823

7.  In vitro activities of and mechanisms of resistance to antifol antimalarial drugs.

Authors:  W K Milhous; N F Weatherly; J H Bowdre; R E Desjardins
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

8.  Influence of medium osmolality on the in vitro growth of Plasmodium falciparum: a morphologic and radioisotopic study.

Authors:  E Dei-Cas; A Wattez; A Vernes
Journal:  In Vitro Cell Dev Biol       Date:  1985-02

9.  In vitro culture and drug sensitivity assay of Plasmodium falciparum with nonserum substitute and acute-phase sera.

Authors:  P Ringwald; F S Meche; J Bickii; L K Basco
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Expression of the essential Kinase PfCDPK1 from Plasmodium falciparum in Toxoplasma gondii facilitates the discovery of novel antimalarial drugs.

Authors:  Rajshekhar Y Gaji; Lisa Checkley; Michael L Reese; Michael T Ferdig; Gustavo Arrizabalaga
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.